NovoCure (NVCR) Change in Cash (2014 - 2026)
NovoCure (NVCR) posted Change in Cash of $6.3 million for Q2 2026, up 203.76% sequentially from -$6.1 million in Q1 2026, and down 72.28% YoY from $22.7 million in Q2 2025.
NovoCure (NVCR) Change in Cash (2014 - 2026) Analysis & Trends
NovoCure has reported Change in Cash for 13 years, with the latest figure at $6.3 million in Q2 2026.
- Quarterly Change in Cash fell 72.28% year-over-year to $6.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$48.5 million (down 197.46% YoY) and the FY2025 annual result came in at -$62.7 million, up 18.0% from the prior year.
- Change in Cash advanced to $6.3 million in Q2 2026 per NVCR's latest filing, from -$6.1 million in the prior quarter.
- Over five years, Change in Cash peaked at $214.8 million in Q1 2024 and troughed at -$288.9 million in Q2 2024.
- A 5-year average of -$5.9 million and a median of -$3.5 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2024 and 2025: Change in Cash surged 2213.65% in 2024, then plunged 944.14% in 2025.
- Over 5 years, Change in Cash stood at -$128.2 million in 2022, then surged by 167.12% to $86.1 million in 2023, then slumped by 126.85% to -$23.1 million in 2024, then slumped by 944.14% to -$241.2 million in 2025, then surged by 102.61% to $6.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $6.3 million, -$6.1 million, and -$241.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 513.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | -890.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 462.20 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -13.20 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -180.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.21 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 42.80 Mn |
| 10 | NovoCure | 2.03 Bn | 1.59 Bn | 142.48 Mn | 6.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29 Mn |
| Mar 31, 2026 | -6.07 Mn |
| Dec 31, 2025 | -241.25 Mn |
| Sep 30, 2025 | 192.51 Mn |
| Jun 30, 2025 | 22.70 Mn |
| Mar 31, 2025 | -36.66 Mn |
| Dec 31, 2024 | -23.11 Mn |
| Sep 30, 2024 | 20.76 Mn |
| Jun 30, 2024 | -288.92 Mn |
| Mar 31, 2024 | 214.80 Mn |
| Dec 31, 2023 | 86.05 Mn |
| Sep 30, 2023 | -982,000.00 |
| Jun 30, 2023 | -29.15 Mn |
| Mar 31, 2023 | 70.81 Mn |
| Dec 31, 2022 | -128.20 Mn |
| Sep 30, 2022 | -123.73 Mn |
| Jun 30, 2022 | 176.14 Mn |
| Mar 31, 2022 | -17.98 Mn |
| Dec 31, 2021 | -481.08 Mn |
| Sep 30, 2021 | 330.11 Mn |